BioAlliance Pharma’s shareholders are invited to attend the Combined Extraordinary and Ordinary General Meeting to be held at 10.00 am on July 27th 2009 at the company’s head office (49 Boulevard du Général Martial Valin, F-75015 Paris, France).
The official notice of the Meeting will be published in the French Republic’s Bulletin des Annonces Légales Obligatoires (“Bulletin of Mandatory Legal Announcements”) and in an official journal of legal announcements on July 10th, 2009. The agenda, the draft resolutions and information on attendance and voting procedures can be viewed on the company’s web site at:
Documents related to the meeting will be made available to shareholders from July 8th onwards, under the conditions set out in the current legislation. Shareholders may, in accordance with Articles R.225-88 and R.225-89 of the French Commercial Code, consult the afore-mentioned documents (together with the information specified in Articles R.225-81 and R.225-83 of the said Code) at the company’s head office or request supply of the said documents and information by post/mail to a duly indicated postal/mailing or electronic address by writing to BioAlliance Pharma (Direction Financière – 49 boulevard du Général Martial Valin, F-75015 Paris, France), faxing to +33 1 45 58 08 81 or sending an e-mail to email@example.com.